TickerFactsScreenerDevelopers

CytomX Therapeutics, Inc. (CTMX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$26.05M2013: -$44.28M2014: -$78.54M2015: $126.07M2016: $78.48M2017: $69.90M2018: $135.83M2019: $25.47M2020: -$7.77M2021: -$459.0K2022: -$85.75M2023: -$47.45M2024: -$456.0K2025: $99.01M$99.01M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$99.01M+21812.3%
2024-$456.0K+99.0%
2023-$47.45M+44.7%
2022-$85.75M-18582.1%
2021-$459.0K+94.1%
2020-$7.77M-130.5%
2019$25.47M-81.2%
2018$135.83M+94.3%
2017$69.90M-10.9%
2016$78.48M-37.7%
2015$126.07M+260.5%
2014-$78.54M-77.4%
2013-$44.28M-70.0%
2012-$26.05M—